Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.

Regul Toxicol Pharmacol

PMI R&D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.

Published: October 2017

Two open-label randomized cross-over studies in Japanese smokers investigated the single-use nicotine pharmacokinetic profile of the Tobacco Heating System (THS) 2.2, cigarettes (CC) and nicotine replacement therapy (Gum). In each study, one on the regular and one on the menthol variants of the THS and CC, both using Gum as reference, 62 subjects were randomized to four sequences: Sequence 1: THS - CC (n = 22); Sequence 2: CC - THS (n = 22); Sequence 3: THS - Gum (n = 9); Sequence 4: Gum - THS (n = 9). Plasma nicotine concentrations were measured in 16 blood samples collected over 24 h after single use. Maximal nicotine concentration (C) and area under the curve from start of product use to time of last quantifiable concentration (AUC) were similar between THS and CC in both studies, with ratios varying from 88 to 104% for C and from 96 to 98% for AUC. Urge-to-smoke total scores were comparable between THS and CC. The THS nicotine pharmacokinetic profile was close to CC, with similar levels of urge-to-smoke. This suggests that THS can satisfy smokers and be a viable alternative to cigarettes for adult smokers who want to continue using tobacco.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yrtph.2017.07.032DOI Listing

Publication Analysis

Top Keywords

nicotine pharmacokinetic
12
sequence ths
12
ths
10
tobacco heating
8
heating system
8
cigarettes nicotine
8
japanese smokers
8
pharmacokinetic profile
8
ths gum
8
ths n = 22
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!